MEU:PA:PA-Lyxor UCITS MSCI Europe D-EUR (EUR)

ETF | Others |

Last Closing

USD 187.13

Change

+3.02 (+1.64)%

Market Cap

USD 0.73B

Volume

1.74K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-15 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.40 (+0.93%)

USD 55.57B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-7.15 (-1.51%)

USD 13.81B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-4.66 (-1.38%)

USD 12.91B
WRD:PA HSBC MSCI World UCITS ETF

-0.33 (-1.06%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.56 (-0.23%)

USD 9.42B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-8.45 (-2.11%)

USD 8.68B
WLD:PA Lyxor UCITS MSCI World D-EUR

-2.86 (-0.93%)

USD 7.98B
HHH:PA HSBC S&P 500 UCITS ETF

-0.79 (-1.65%)

USD 7.67B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.03 (-0.57%)

USD 6.16B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

-0.60 (-0.80%)

USD 5.54B

ETFs Containing MEU:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.40% 83% B 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.40% 82% B 70% C-
Trailing 12 Months  
Capital Gain 4.95% 68% D+ 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.95% 64% D 68% D+
Trailing 5 Years  
Capital Gain 74.74% 64% D 71% C-
Dividend Return 2.06% 3% F 3% F
Total Return 76.80% 62% D 67% D+
Average Annual (5 Year Horizon)  
Capital Gain 11.80% 67% D+ 70% C-
Dividend Return 11.97% 65% D 83% B
Total Return 0.17% 18% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 11.44% 56% F 87% B+
Risk Adjusted Return 104.66% 84% B 94% A
Market Capitalization 0.73B 72% C 74% C

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.